The Cloning the Human Response technology can be applied to many different targets, ranging from infectious diseases to oncology and from neurodegenerative diseases to parasitic infections. If there is a donor available, either through vaccination or through recovering from the disease, IQ can apply its proprietary technology in order to develop life saving medicines.
IQ is always looking for new opportunities and welcomes proposals for various levels of collaboration.
Subscribe to our RSS Feed 